# A Phase II Study of AS1411 in Renal Cell Carcinoma

> **NCT00740441** · PHASE2 · UNKNOWN · sponsor: **Antisoma Research** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** AS1411

## Key facts

- **NCT ID:** NCT00740441
- **Lead sponsor:** Antisoma Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-08
- **Primary completion:** 2009-09
- **Final completion:** 2010-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740441, "A Phase II Study of AS1411 in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00740441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*